Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)

Kyung Nam Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	44,411	50,814	25,960	42,992	22,931	22,728
Short-Term Investments	-	-	0	500	0	-
Trading Asset Securities	-	-	9,053	1,985	316.23	4,766
Cash & Short-Term Investments	44,411	50,814	35,013	45,478	23,248	27,495
Cash Growth	31.85%	45.13%	-23.01%	95.62%	-15.45%	14.86%
Accounts Receivable	13,616	14,124	18,321	13,753	16,063	19,536
Other Receivables	436.21	62.98	602.48	116.91	337.14	82.16
Receivables	14,052	14,187	19,314	13,870	16,451	19,670
Inventory	13,197	12,215	13,478	12,611	13,979	9,664
Prepaid Expenses	73.22	125.14	508.29	1,050	976.54	157
Other Current Assets	316.92	484.01	985.2	1,729	265.91	653.05
Total Current Assets	72,050	77,825	69,298	74,738	54,920	57,639
Property, Plant & Equipment	32,723	32,327	46,710	31,235	33,852	32,227
Long-Term Investments	14,674	16,560	5,426	-	-	-
Goodwill	-	-	4,190	-	139.69	139.69
Other Intangible Assets	335.36	368.38	5,454	804.76	924.01	620.12
Long-Term Accounts Receivable	-0	-0	0	-0	-0	0
Long-Term Deferred Tax Assets	118.31	135.03	881.21	1,922	7,530	7,678
Other Long-Term Assets	40,318	39,369	34,650	29,568	27,940	28,352
Total Assets	160,219	166,584	166,609	138,269	125,307	126,655
Accounts Payable	4,322	5,557	7,242	3,366	4,430	6,341
Accrued Expenses	707.07	755.58	1,134	532.96	566.29	805.93
Short-Term Debt	7,065	9,396	17,497	8,776	11,415	11,618
Current Portion of Long-Term Debt	24,000	24,000	24,185	24,000	1,800	1,800
Current Portion of Leases	203.68	115.62	563.48	220.1	342.5	296.41
Current Income Taxes Payable	-	1.69	56.76	0.86	0.77	-
Current Unearned Revenue	-	-	215.02	-	-	-
Other Current Liabilities	4,614	6,453	16,039	7,051	6,857	17,744
Total Current Liabilities	40,911	46,279	66,933	43,947	25,411	38,605
Long-Term Debt	4,000	4,000	8,760	-	25,650	27,450
Long-Term Leases	438.52	74.87	324.71	197.08	308.13	228.1
Other Long-Term Liabilities	6	373.11	759.43	354.33	592.33	836.36
Total Liabilities	46,729	51,361	76,777	44,498	52,778	69,291
Common Stock	7,815	7,815	17,797	16,740	10,025	8,721
Additional Paid-In Capital	127,603	141,835	104,275	98,061	72,237	56,009
Retained Earnings	-24,081	-36,570	-45,041	-23,102	-11,506	-9,173
Treasury Stock	-1.08	-1.08	-1.08	-1.08	-1.08	-1.08
Comprehensive Income & Other	2,155	2,144	2,332	2,074	1,774	1,807
Total Common Equity	113,490	115,223	79,362	93,771	72,529	57,364
Minority Interest	-	-	10,471	-	-	-
Shareholders' Equity	113,490	115,223	89,832	93,771	72,529	57,364
Total Liabilities & Equity	160,219	166,584	166,609	138,269	125,307	126,655
Total Debt	35,707	37,587	51,330	33,193	39,515	41,392
Net Cash (Debt)	8,705	13,228	-16,318	12,285	-16,268	-13,898
Net Cash Per Share	160.78	304.34	-460.29	421.03	-712.04	-805.76
Filing Date Shares Outstanding	78.15	78.15	35.59	33.48	20.05	17.44
Total Common Shares Outstanding	78.15	78.15	35.59	33.48	20.05	17.44
Working Capital	31,139	31,546	2,365	30,792	29,509	19,035
Book Value Per Share	1452.27	1474.44	2229.69	2800.84	3617.53	3288.78
Tangible Book Value	113,155	114,855	69,717	92,966	71,465	56,604
Tangible Book Value Per Share	1447.97	1469.73	1958.73	2776.81	3564.48	3245.22
Land	-	20,049	27,988	17,715	15,707	15,707
Buildings	-	11,337	13,013	10,979	9,860	9,754
Machinery	-	10,049	13,168	10,648	10,553	7,733
Construction In Progress	-	184.45	888.2	164.4	4,974	6,379

Source: S&P Global Market Intelligence. Standard template. Financial Sources.